Natriuretic peptides: Physiological, pathophysiological and clinical aspects;Natriuretische peptide: Physiologische, pathophysiologische und klinische aspekte

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 36, Issue 7, 2001, Pages 406-416

  Michels, P ^a   Tarnow, J ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Congestive heart failure; Heart transplantation; Natriuretic peptides; Renal failure

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; URODILATIN;

ACUTE KIDNEY FAILURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIAGNOSTIC VALUE; HUMAN; PROGNOSIS; PROPHYLAXIS; PROTEIN FAMILY; REVIEW; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; EXONS; HEART; HUMANS; KIDNEY DISEASES; MOLECULAR SEQUENCE DATA; NATRIURESIS; RATS; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 0034925796     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15433     Document Type: Review

References (123)

1. Body Water
2. Evidence of the atrial location of receptors influencing urine flow
3. Humoral nature of the urine response to stimulation of atrial receptors
4. Electron microscopy of the atrium of the heart
5. Specific granules in atrial muscle cells
6. A rapid and potent natriuretic response to intravenous injection of atrial extracts in rats
7. Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria
8. The right auricle of the heart is an endocrine organ: Cardiodilatin as a peptide hormone candidate
9. Rat atrial natriuretic factor: Purification and vasorelaxant activity
10. The right auricle of the heart is an endocrine organ: Cardiodilatin as a peptide hormone candidate
11. The amino acid sequence of an atrial petide with potent diuretic and natriuretic properties
12. Purification and complete amino acid sequence of a-human atrial natriuretic polypeptide (a-hANP)
13. Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide
14. The heart and the atrial natriuretic factor
15. Purification and sequence analysis of bioactive atrial peptides (atriopeptins)
16. Rat atrial natriuretic factor: Purification and vasorelaxant activity
17. The auricular myocardiocytes of the heart constitute an endocrine organ. Characterization of a porcine cardiac peptide hormone, cardiodilatin-126
18. Isolation and structural analysis of the circulating human cardiodilatin (alpha ANP)
19. Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasma
20. A new natriuretic peptide in porcine brain
21. C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain
22. The endocrine heart and natriuretic peptides: Histochemistry, cell biology, and functional aspects of the renal urodilatin system
23. Atrial natriuretic peptide
24. Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands
25. Erhöhte konzentrationen des atrialen natriuretischen peptids im plasma und im herzvorhof bei patienten mit aorten- und mitralvitien im vergleich zu patienten mit koronarer herzkrankheit
26. Atrial natriuretic peptide: Synthesis, release, and metabolism
27. Biochemistry of natriuretic peptides
28. Natriuretic hormones
29. Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue
30. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor B: Possible existence of "vascular natriuretic peptide system"
31. Natriuretic peptides
32. Cellular localisation of atrial natriuretic factor in the human kidney
33. Atrial natriuretic peptid in human urine
34. Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine
35. Urodilatin: A natriuretic peptide or renal origin
36. Atrial natriuretic peptide increases urodilatin in the circulation
37. Characterization of ANP receptors in rabbit inner medullary collecting duct cells
38. Molecular biology of the natriuretic peptide and their receptors
39. Effect of urodilatin on cGMP accumulation in the kidney
40. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction
41. Receptors of atrial natriuretic factor
42. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)
43. Differential activation of the human natriuretic peptide receptor guanylyl cyclase
44. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog
45. Biochemistry of the differential release, processing and degradation of cardiac and related peptide hormones
46. Role of endopeptidase 24.11 in the inactivation of atrial natriuretic peptide
47. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11
48. Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (a-hANP/CDD-99-126)
49. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man
50. Atriopeptin: A cardiac hormone intimately involved in fluid, electrolyte and blood-pressure homeostasis
51. Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man
52. Atrial natriuretic peptide: Physiological release associated with natriuresis during water immersion in man
53. Atrial natriuretic factor and renal function during head-out water immersion in conscious dogs
54. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion
55. Effect of water immersion on renal natriuretic peptide (urodilatin) excretion in humans
56. Effects of posture and aging in circulating atrial peptide levels in man
57. Sodium loading and posture modulate human atrial natriuretic factor plasma levels
58. Effect of posture on plasma immunoreactive atrial natriuretic peptide concentrations in man
59. Atrial natriuretic peptide is release by dynamic exercise in man
60. Atrial natriuretic hormones - Thirty years after the discovery of atrial volume receptors
61. Studies on the secretion, metabolism and action of atrial natriuretic peptide in man
62. Atrial natriuretic peptide in man
63. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide
64. Natriuretic peptides
65. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney
66. Effect of atriopeptin III on determinants of glomerular filtration rate in the vitro perfused dog glomerulus
67. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease
68. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption
69. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide
70. Hormonal regulation of the inner medullary collecting duct sodium transport
71. Regulation of atrial natriuretic peptide receptors in glomeruli during chronic salt loading
72. Endothelin increases atrial natriuretic peptide production in cultured rat diencephalic neurons
73. Arginine vasopressin stimulates atrial natriuretic peptide gene expression and secretion from rat diencephalic neurons
74. Norepinephrine stimulates immunoreactive (ir) atrial natriuretic peptide (anp) secretion and pro-ANP mRNA expression from rat hypothalamic neurons in culture: Effect of α2-adrenoceptors
75. Recent advances in ANF research
76. The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus
77. Central oxytocin and ANP receptors mediate osmotic inhibition of salt appetite in rats
78. Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans
79. Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii
80. The effect of α human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjects
81. Diverse biological actions of atrial natriuretic peptide
82. The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides
83. Recent advances in ANF research
84. Beneficial effect of the atrial natriuretic factor analog A68828 on recovery from ischemic acute renal failure
85. Norepinephrine-induced acute renal failure: Beneficial effects of atrial natriuretic factor
86. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function
87. Toxic acute renal failure in the rat: Effects of diltiazem and urodilatin on renal function
88. Effects of atrial natriuretic peptide in clinical acute renal failure
89. Comparative effects of urodilatin and atrial natriuretic factor on renal function in the rat
90. Urodilatin, not nitroprusside, combined with dopamine reverses ischemic acute renal failure
91. Urodilatin: A new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients
92. Significance of prophylactic Urodilatin (INN: Ularitide) infusion for prevention of acute renal failure in patients after heart transplantation
93. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity
94. Urodilatin: A new approach for the treatment of therapy-resistant acute renal failure after liver-transplantation
95. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN:Ularitide)
96. Anaritide in acute tubular necrosis
97. Therapeutic use of the natriuretic peptide ularitide in acute renal failure
98. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP
99. Kardiale peptide und ihre bedeutung bei der herzinsuffizienz
100. Atrial natriuretic peptide elevation in congestive heart failure in the human
101. Prognostic importance of arterial natriuretic peptide in patients with chronic heart failure
102. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
103. Biochemical detection of left-ventricular systolic dysfunction
104. Cardiovascular and renal functional effects of an antagonist of the guanylyl cyclase-linked ANF receptor
105. Cardiorenal and neurohumeral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors
106. Atrial natriuretic peptide in congestive heart failure in the dog: Plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects
107. Human atrial natriuretic peptide: Plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure
108. Haemodynamic effects of atrial natriuretic peptide infusion in heart failure
109. Clinical application of atrial natriuretic polypetide in patients with congestive heart failure: Beneficial effects on left ventricular function
110. Effects of ANP-(95-126) in dogs before and after induction of heart failure
111. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure
112. Hemodynamic and Renal Excretory Effects of Human Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure
113. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
114. Neuroendocrine response to cardiac transplantation
115. Transient reduction without normalization of brain natriuretic peptide early after heart transplantation
116. Raised concentration of atrial natriuretic peptides in cardiac transplant recipients
117. Significance of Raised Natriuretic Peptides After Bicaval and Standard Cardiac Transplantation
118. Discoordinate Modulation of Natriuretic Peptides During Acute Cardiac Allograft Rejection in Humans
119. Type A natriuretic peptides exhibit different bronchoprotective effects in rats
120. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites
121. Urodilatin (Ularitide, INN): A potent bronchodilator in asthmatic subjects
122. Bronchodilating effects of natriuretic and vasorelaxant peptides compared to salbutamol in asthmatics